Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.09 USD
−123.57 M USD
0.00 USD
22.08 M
About HilleVax, Inc.
Sector
Industry
CEO
Robert M. Hershberg
Website
Headquarters
Boston
Founded
2020
FIGI
BBG012FCPWH5
HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HLVX is 1.86 USD — it has increased by 2.20% in the past 24 hours. Watch HilleVax, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange HilleVax, Inc. stocks are traded under the ticker HLVX.
HLVX stock has fallen by −4.12% compared to the previous week, the month change is a 1.64% rise, over the last year HilleVax, Inc. has showed a −86.66% decrease.
We've gathered analysts' opinions on HilleVax, Inc. future price: according to them, HLVX price has a max estimate of 3.00 USD and a min estimate of 2.00 USD. Watch HLVX chart and read a more detailed HilleVax, Inc. stock forecast: see what analysts think of HilleVax, Inc. and suggest that you do with its stocks.
HLVX reached its all-time high on Sep 14, 2022 with the price of 24.42 USD, and its all-time low was 1.55 USD and was reached on Jul 8, 2024. View more price dynamics on HLVX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HLVX stock is 4.37% volatile and has beta coefficient of 1.67. Track HilleVax, Inc. stock price on the chart and check out the list of the most volatile stocks — is HilleVax, Inc. there?
Today HilleVax, Inc. has the market capitalization of 92.64 M, it has decreased by −0.55% over the last week.
Yes, you can track HilleVax, Inc. financials in yearly and quarterly reports right on TradingView.
HilleVax, Inc. is going to release the next earnings report on Mar 14, 2025. Keep track of upcoming events with our Earnings Calendar.
HLVX earnings for the last quarter are −0.52 USD per share, whereas the estimation was −0.42 USD resulting in a −24.71% surprise. The estimated earnings for the next quarter are −0.38 USD per share. See more details about HilleVax, Inc. earnings.
HilleVax, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
HLVX net income for the last quarter is −25.82 M USD, while the quarter before that showed −40.67 M USD of net income which accounts for 36.50% change. Track more HilleVax, Inc. financial stats to get the full picture.
No, HLVX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 90.00 employees. See our rating of the largest employees — is HilleVax, Inc. on this list?
Like other stocks, HLVX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HilleVax, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HilleVax, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HilleVax, Inc. stock shows the sell signal. See more of HilleVax, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.